Promoter Bank clone, Human cyclin A1 promoter
|
Other clones in our bank
External Database Human cyclin A1 Reference sequence AF124143, AL359767 |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions set forth by the DEPOSITOR | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
---|---|
Additional terms and conditions for distribution | The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
Ordering | Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] |
提供条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 |
---|---|
付加的提供条件 | 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05482 | pKM2L-phCYCA1 | DNA solution |
Electronic file
Original reference
Further references such as user reports and related articles (go to bottom)
Featured content
Featured content | Promoter Collection (Renilla Luciferase) (English text) |
---|
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB05482_A3L9.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB05482_A3L9a.seq |
---|
>05482_05482-A3L9_3_M13(-40)_E09_15.ab1 1 CGGCGGGCCA GCTTGCATGC CTGCAGGTCA TTTAAATAGG GATAACAGGG TAATGATTAA 61 GATCTCGAGC TCTAAGCTTC ACATATGCAT GCACTAGTGG CCAGACTATA GCATTGGTAA 121 TGTGTGTGTG CATATATACA TATTATTTTT AAAAAAATAA AGTTCGATTA TTTCACCTGG 181 CTTGTCAGTC ACCTATGCAG GCGTCTGAGC CCCCGGGTTT CCAGGAGCCC CCCGTATAAG 241 GACCCCAGGG ACTCCTCTCC CCACGCGGCC GGGCCGCCCG CCCGGCCCCC AGCCCGGAGA 301 GCTGCCACCG ACCCCCTCAA CGTCCCAAGC CCCAGCTCTG TCGCCCGCGT TCCTTCCTCT 361 TCCTGGGCCA CAATCTTGGC TTTCCCGGGC CGGCTTCACG CAGTTGCGCA GGAGCCCGCG 421 GGGGAAGACC TCTCGTGGGG ACCTCGAGCA CCACGTGCGA CCCTAAATCC CCACATCTCC 481 TCTGCCGCCT CGCAGGCCAC ATGCACCGGG AGCCGGGCGG GGCAGGCGCG GCCCGCAAGG 541 ACCCCCGCGA TGGAGACGCA ACACTGCCGC GACTGCACTT GGGGCAGCCC CGCCGCGTCC 601 CAGCCGCCTC CCGGCAGGAA GCGTAGGTGT GTGAGCCGAC CCGGAGCGAG CCGCGCCCTC 661 GGGCCAGCGT GGGC // |
Primer: Sequence file: RDB05482_A3L9b.seq |
>05482_05482-A3L9_3_phRLR2_F09_18.ab1 1 ACTCCCCTGT CTCGACAGCC CAGTTTCTAT TGGTCTCCTT AAACCTGTCT TGTAACCTTG 61 ATACTTACCT GCCCAGTGCC TCACGACCAA CTTCTGCAGT ACCCGGGTGA ATTCTACGCG 121 TCGACAGGCT TCCCGTCGTT ATCTTTCTAT GTGTCCGGAA CAACTGGCAA GTGCACTGGA 181 GGATCGCGGT TAAGAGGTGG CCGGCTGGGC GGGGCAGGGC GGGGCAGGGT TGGGCAGGGC 241 CGGGCCGGGC CGGGCGGGGC AGGGCGGGGA AGGGCAGGGA AGGGCAGGGC ACGGAAGGGC 301 GGGGCGGGAA GGACCAAGTG TCGAGGGATT CCAGCCTGGG AGGCGGCCGG GCTTAGCGAT 361 GCGGCTGAGC TGCCCACCCG CGTCTGTTGA ATCGGCCAAT CAGCGGCGCC CCCGGACCTA 421 GCGGGAGCGT TTCCATGCCG ACCGCGGCAG GCGTGCGCTC TCCGGGGCCG CATCGCCATG 481 GCGACCTGCT CACCTGACTC GCTCCGGGTG GACTCGCCGC GACCCCTGGG CGTTCAGGCC 541 CCTGAGGGCC CAACGGGCGA CGGCCCTCCA GCTCCAGCTG TGCGTCTCCG CCCGGGCGAG 601 GTGGGGCTGA CCGCGGCCGT CTGCACACGT CCCCTCTGGT CCGCGCCCCC GGCCTGGGAG 661 GGCGGACTCG CC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
2022.05.18
GNP_filter3_RDBDEP_html_220516.pl